Tyrosine kinase inhibitors for the treatment of indolent systemic mastocytosis: Are we there yet?
Author:
Funder
Incyte
Pfizer
Austrian Science Fund
Novartis
Celgene
Publisher
Elsevier BV
Subject
Immunology,Immunology and Allergy
Reference43 articles.
1. The Data Registry of the European Competence Network on Mastocytosis (ECNM): set up, projects, and perspectives;Valent;J Allergy Clin Immunol Pract,2019
2. Diagnostic criteria and classification of mastocytosis: a consensus proposal;Valent;Leuk Res,2001
3. Mastocytosis: 2016 updated WHO classification and novel emerging treatment concepts;Valent;Blood,2017
4. Clinical features and survival of patients with indolent systemic mastocytosis defined by the updated WHO classification;Trizuljak;Allergy,2020
5. Mast cell activation syndrome and mastocytosis: initial treatment options and long-term management;Castells;J Allergy Clin Immunol Pract,2019
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Intermediate-based virtual screening of c-Kit kinase inhibitors as potential anti-tumor agents via ab inito folding, molecular dynamics simulation, and molecular docking;Arabian Journal of Chemistry;2024-10
2. Mast cells: The unregulated master immune response conductor;Allergy Medicine;2024-09
3. Standardized indolent systemic mastocytosis evaluations across a health care system: implications for screening accuracy;Blood;2024-07-25
4. SOHO State of the Art Update and Next Questions: Current and Emerging Therapies for Systemic Mastocytosis;Clinical Lymphoma Myeloma and Leukemia;2024-06
5. Mastozytose – eine häufig unerkannte Erkrankung;best practice onkologie;2024-04-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3